Clinical Trial Update: Early Liver Disease Breath Detection

View source ↗

Summary

Owlstone Ltd reports an early-stage trial update evaluating breath-based detection for liver disease, including liver fibrosis and nonalcoholic steatohepatitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Owlstone Ltd | Conditions: Liver Fibrosis, NASH | Status: UNKNOWN